SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2019-09-18 14:36
Tx date 2019-09-13 		$KLY
Kalytera Therapeutics, Inc. 		Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption 		$98,647
+1,972,950 vol
$0.05 each 		1,972,950
Filed 2019-09-18 14:34
Tx date 2016-12-30 		$KLY
Kalytera Therapeutics, Inc. 		Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2019-09-18 14:34
Tx date 2019-09-13 		$KLY
Kalytera Therapeutics, Inc. 		Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$98,647
+1,972,950 vol
$0.05 each 		1,972,950
Filed 2019-09-18 14:33
Tx date 2016-12-30 		$KLY
Kalytera Therapeutics, Inc. 		Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-06-24 10:02
Tx date 2019-06-19 		$KLY
Kalytera Therapeutics, Inc. 		Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+11,095,907 vol 		24,966,756
Filed 2019-06-24 10:01
Tx date 2019-06-19 		$KLY
Kalytera Therapeutics, Inc. 		Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+11,095,907 vol
Filed 2019-06-24 09:57
Tx date 2019-06-19 		$KLY
Kalytera Therapeutics, Inc. 		Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+11,095,907 vol
Filed 2019-06-24 09:57
Tx date 2019-06-19 		$KLY
Kalytera Therapeutics, Inc. 		Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+11,095,907 vol 		24,966,756
Filed 2019-01-28
Tx date 2019-01-25 		$KALY
Kalytera Therapeutics, Inc. 		Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+1,246,092 vol 		13,870,849
Filed 2018-09-27
Tx date 2018-09-24 		$KALY
Kalytera Therapeutics, Inc. 		Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+5,117,794 vol 		12,624,757
Filed 2018-01-31
Tx date 2018-01-30 		$KALY
Kalytera Therapeutics, Inc. 		Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+1,045,210 vol 		7,506,963
Filed 2017-12-06
Tx date 2017-10-08 		$KALY
Kalytera Therapeutics, Inc. 		Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+5,473,442 vol 		6,461,753
Filed 2017-01-09
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-09
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
+988,311 vol 		988,311